Kadhim, A. A., Jamal, M. Y. and Karim, A. K. (2025) “Natalizumab Immunogenicity in Multiple Sclerosis: Evaluating Antibody Development and Clinical Outcomes in an Iraqi Cohort”, Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 9(2), pp. 83–89. doi: 10.54133/ajms.v9i2.2352.